CoChat

Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders

Open access
Eleftheriou, Georgios, Zandonella Callegher, Riccardo, Butera, Raffaella, De Santis, Marco, Cavaliere, Anna Franca, Vecchio, Sarah, Pistelli, Alessandra, Mangili, Giovanna, Bondi, Emi, Somaini, Lorenzo, Gallo, Mariapina, Balestrieri, Matteo, Albert, Umberto · 2023 · International Journal of Environmental Research and Public Health

The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.

Abstract

Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug use in pregnancy is developing in an area of clinical uncertainty. Although many studies have been published in recent years, there is still a paucity of authoritative evidence-based indications useful for guiding the prescription of these drugs during pregnancy, and the data from the literature are complex and require expert judgment to draw clear conclusions. Methods: For the elaboration of the consensus, we have involved the scientific societies of the sector, namely, the Italian Society of Toxicology, the Italian Society of Neuropsychopharmacology, the Italian Society of Psychiatry, the Italian Society of Obstetrics and Gynecology, the Italian Society of Drug Addiction and the Italian Society of Addiction Pathology. An interdisciplinary team of experts from different medical specialties (toxicologists, pharmacologists, psychiatrists, gynecologists, neonatologists) was first established to identify the needs underlying the consensus. The team, in its definitive structure, includes all the representatives of the aforementioned scientific societies; the task of the team was the evaluation of the most accredited international literature as well as using the methodology of the “Nominal Group Technique” with the help of a systematic review of the literature and with various discussion meetings, to arrive at the drafting and final approval of the document. Results: The following five areas of investigation were identified: (1) The importance of management of anxiety and depressive disorders in pregnancy, identifying the risks associated with untreated maternal depression in pregnancy. (2) The assessment of the overall risk of malformations with the antidepressant and anxiolytic drugs used in pregnancy. (3) The evaluation of neonatal adaptation disorders in the offspring of pregnant antidepressant/anxiolytic-treated women. (4) The long-term outcome of infants’ cognitive development or behavior after in utero exposure to antidepressant/anxiolytic medicines. (5) The evaluation of pharmacological treatment of opioid-abusing pregnant women with depressive disorders. Conclusions: Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on the pregnancy and on the fetal outcome, and of the comparative risk between the treatment and the absence of treatment; in the choice prescription, the specialist needs to be aware of both the potential risks of pharmacological treatment and the equally important risks of an untreated or undertreated disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijerph20166565

Cites

262 of 262 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Anbalagan S. Mendez M.D. Neonatal Abstinence Syndrome StatPearls Treasure Island, FL, USA 2023 31855342
  2. Schloemp S. Paulus W.E. Sterzik K. Stoz F. Congenital malformations after antidepressant medication with paroxetine in early pregnancy? Hum. Reprod. 2006 21 (Suppl. 1) i12
  3. National Institute for Health and Care Excellence (NICE) Surveillance of Pregnancy and Complex Social Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors (NICE Guideline CG110) National Institute for Health and Care Excellence (NICE) London, UK 2018 Bookshelf ID: NBK551070 31855334

Cited by

See all 17

Metadata

Authors
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., Gallo, M., Balestrieri, M., & Albert, U.
Affiliations
  • Ospedale Papa Giovanni XXIII (IT)
  • Italian Society of Psychiatry (SIP), piazza Santa Maria della Pietà 5, 00135 Rome, Italy
  • Italian Society of Obstetrics and Gynecology (SIGO), via di Porta Pinciana 6, 00187 Rome, Italy
  • Italian Society of Toxicology (SITOX), via Giovanni Pascoli 3, 20129 Milan, Italy
  • Azienda Ospedaliero-Universitaria Careggi (IT)
  • Ser.D Biella—Drug Addiction Service, 13875 Biella, Italy
  • University of Udine (IT)
  • University of Trieste (IT)
Corresponding author
Eleftheriou, Georgios
Venue
International Journal of Environmental Research and Public Health
Publisher
MDPI AG
Published
2023-08-11
Volume
20
Issue
16
Pages
6565
ISSN
1660-4601 (ISSN-L)
OpenAlex
W4385759437
Cited by
17
References
262
Citations by year
2026: 6 · 2025: 9 · 2024: 2
FWCI
4.34
Type
journal article
Language
en
Open access
Locations
  • International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antidepressant use in pregnancy, fetal malformations, infant cognitive development, opioid use disorder in pregnancy, risk-benefit assessment, consensus recommendations, prenatal drug exposure, neonatal abstinence syndrome, maternal and fetal outcomes
MeSH terms
Clinical Decision-Making, Depressive Disorder, Female, Humans, Infant, Infant, Newborn, Pregnancy, Psychiatry, Anti-Anxiety Agents, Uncertainty, Pregnant People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.